Remove tag real-world-evidence
article thumbnail

5 Things I Love About The MAD-ID Conference, The Antimicrobial Stewardship Meeting

IDStewardship

It has claimed the tag line “The Antimicrobial Stewardship Meeting.” Putting Faces to Names and Making New Connections In the virtual world we live in, it is pretty easy to make connections through social media with folks across great geographic distances (shout out to #IDtwitter). That was possible because of MAD-ID.

article thumbnail

FDA slammed over Aduhelm OK as Biogen takes heat for $56k price tag

pharmaphorum

In a statement on the approval, ICER said the view of many experts was that current evidence is simply not enough to support the use of aducanumab in Alzheimer’s patients, and the FDA had “moved the goalposts” by not holding Biogen’s drug to the standards of other therapies.

FDA 98
article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

The way we challenge the status quo is to provide a proven blueprint for optimizing well-being through world-class benefits that are affordable, often costing 30-50 percent less and providing easy access through our ecosystem to align benefits advisors. In that market, the real Market, my view prices have been flat for 5 to 10 years.